Delivery Order SPE2DB20D2104-SPE2DB20FQ80Q
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $10,711.98 delivery order covers the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials like syringes and...
- This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, over-the-counter items, and critical care materials such as syringes and vials,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,185.50 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,764.06 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials, to support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, represents a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,915.15. The IDC, worth up to $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for a Delivery Order valued at $4,973.16 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, represents a Delivery Order valued at $1,283.74 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FQ80QDelivery Order
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,529.85, is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical healthcare commodities. The IDC with the DLA, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical and medical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This contract award does not have a set-aside designation, indicating open competition. The parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/14/20 |